Correlation Between Oncologix Tech and TransAKT
Can any of the company-specific risk be diversified away by investing in both Oncologix Tech and TransAKT at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncologix Tech and TransAKT into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncologix Tech and TransAKT, you can compare the effects of market volatilities on Oncologix Tech and TransAKT and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncologix Tech with a short position of TransAKT. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncologix Tech and TransAKT.
Diversification Opportunities for Oncologix Tech and TransAKT
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Oncologix and TransAKT is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Oncologix Tech and TransAKT in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TransAKT and Oncologix Tech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncologix Tech are associated (or correlated) with TransAKT. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TransAKT has no effect on the direction of Oncologix Tech i.e., Oncologix Tech and TransAKT go up and down completely randomly.
Pair Corralation between Oncologix Tech and TransAKT
If you would invest 1.01 in TransAKT on September 17, 2024 and sell it today you would earn a total of 8.99 from holding TransAKT or generate 890.1% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Oncologix Tech vs. TransAKT
Performance |
Timeline |
Oncologix Tech |
TransAKT |
Oncologix Tech and TransAKT Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Oncologix Tech and TransAKT
The main advantage of trading using opposite Oncologix Tech and TransAKT positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncologix Tech position performs unexpectedly, TransAKT can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TransAKT will offset losses from the drop in TransAKT's long position.Oncologix Tech vs. Grey Cloak Tech | Oncologix Tech vs. CuraScientific Corp | Oncologix Tech vs. Love Hemp Group | Oncologix Tech vs. Greater Cannabis |
TransAKT vs. Absolute Health and | TransAKT vs. Embrace Change Acquisition | TransAKT vs. Supurva Healthcare Group | TransAKT vs. China Health Management |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
CEOs Directory Screen CEOs from public companies around the world |